Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Aveanna Healthcare Holdings Inc(AVAH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AVAH
10/28/2026: AVAH (3-star) is currently NOT-A-BUY. Pass it for now.
Aveanna Healthcare Holdings Inc is a national provider of home-based nursing, medical supplies, and hospice care. The company has a leading position in the specialized pediatric nursing market, which provides a durable foundation for its business. Its primary growth opportunity lies in scaling higher-margin hospice services and transitioning toward value-based care agreements. However, the company faces significant risks from high debt levels, labor cost inflation, and heavy reliance on government reimbursement rates. The stock may best suit growth-oriented investors with a high risk tolerance who are looking for exposure to the long-term trend of home-based care, while monitoring debt reduction progress and staffing trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers growth potential in home care, but high debt levels and margin pressures moderate the growth case. |
| Momentum investor | Weak fit | The stock has experienced significant volatility and is not currently exhibiting strong, consistent bullish momentum. |
| Value investor | Mixed fit | The company may appear attractively valued relative to its revenue, but debt obligations complicate the fundamental valuation. |
| Dividend investor | Weak fit | The company does not pay a dividend and has no near-term stated plans to initiate one. |
| Low-risk investor | Weak fit | High leverage and reliance on government reimbursement rates introduce risks inconsistent with a low-risk profile. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock's history since IPO shows significant swings, reflecting uncertainty in operational turnaround efforts. |
| Valuation risk | Medium | Market pricing is sensitive to interest rate environments and the company's ability to service its debt. |
| Competition risk (labor and pricing) | High | Intense competition for clinical staff drives up costs, which may not always be offset by government reimbursement increases. |
| Business quality | Medium | While the clinical platform is well-regarded, operational execution and margins have been inconsistent. |
| Dividend income | Low / none | There is no current dividend, providing no income component to total return. |
| Execution risk | Medium / high | Management must successfully integrate past acquisitions while simultaneously de-leveraging the balance sheet. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -1.96% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/28/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.77B USD | Price to earnings Ratio 10.08 | 1Y Target Price 15.05 |
Price to earnings Ratio 10.08 | 1Y Target Price 15.05 | ||
Volume (30-day avg) 2.7M shares | Beta 1.95 | 52 Weeks Range 5.93 - 14.71 | Updated Date 10/28/2026 |
52 Weeks Range 5.93 - 14.71 | Updated Date 10/28/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.26 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Private Duty Nursing | Clinical nursing care provided to patients in their homes. | This is the company's largest revenue generator, providing necessary care to medically fragile individuals. |
| Medical Solutions | Durable medical equipment, nutritional products, and home health supplies. | This segment provides recurring revenue through the consistent need for medical supplies and nutrition. |
| Home Health & Hospice | Clinical and end-of-life care services. | These services offer higher profit margins and are a key area for growth and expansion. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 10.08 | Forward PE 13.72 | Enterprise Value 4.29B | Price to Sales(TTM) 1.07 |
Enterprise Value 4.29B | Price to Sales(TTM) 1.07 | ||
Enterprise Value to Revenue 1.65 | Enterprise Value to EBITDA 14.1 | Shares Outstanding 218.29M | Shares Floating 104.42M |
Shares Outstanding 218.29M | Shares Floating 104.42M | ||
Percent Insiders 5.64 | Percent Institutions 94.14 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.